Guardian Pharmacy Services (GRDN) Stock Overview
A pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
GRDN Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Guardian Pharmacy Services, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$40.80 |
| 52 Week High | US$41.36 |
| 52 Week Low | US$19.17 |
| Beta | 0 |
| 1 Month Change | 9.56% |
| 3 Month Change | 28.38% |
| 1 Year Change | 95.03% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 155.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| GRDN | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 5.3% | 2.2% | -0.1% |
| 1Y | 95.0% | 17.0% | 26.3% |
Return vs Industry: GRDN exceeded the US Healthcare industry which returned 12.4% over the past year.
Return vs Market: GRDN exceeded the US Market which returned 26.2% over the past year.
Price Volatility
| GRDN volatility | |
|---|---|
| GRDN Average Weekly Movement | 5.5% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GRDN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: GRDN's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 3,600 | Fred Burke | guardianpharmacy.com |
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company’s individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.
Guardian Pharmacy Services, Inc. Fundamentals Summary
| GRDN fundamental statistics | |
|---|---|
| Market cap | US$2.48b |
| Earnings (TTM) | US$53.07m |
| Revenue (TTM) | US$1.46b |
Is GRDN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GRDN income statement (TTM) | |
|---|---|
| Revenue | US$1.46b |
| Cost of Revenue | US$1.15b |
| Gross Profit | US$304.68m |
| Other Expenses | US$251.61m |
| Earnings | US$53.07m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.84 |
| Gross Margin | 20.93% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 0% |
How did GRDN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/04 11:42 |
| End of Day Share Price | 2026/06/04 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Guardian Pharmacy Services, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Allen Lutz | BofA Global Research |
| Kam Wai Kwok | CGS International |
| Brian Tanquilut | Jefferies LLC |